期刊文献+

三种代谢综合征定义在中国冠心病患者中的应用比较 被引量:2

Comparison of application of three diagnostic criteria of metabolic syndrome in patients with coronary heart disease in China
暂未订购
导出
摘要 目的探讨ATPⅢ(2001)、CDS(2004)、IDF(2005)等三种代谢综合征定义在中国冠心病人群中应用价值。方法于2005年6月1日至2005年9月30日期间在北京、上海、广州等7个城市共52家三级甲等医院心内科所有符合冠心病诊断纳入条件的住院患者连续入选为研究对象,共收集有效病例3 513例。分别应用ATPⅢ、CDS以及IDF的工作定义诊断MS,比较各定义下的MS的患病率以及通过运用ROC曲线来考查这三种工作定义两两间比较的一致性情况。结果ATPⅢ、CDS以及IDF工作定义下冠心病患者MS患病率分别为40.2%、52.8%和53.5%。ROC曲线特征:CDS为参照下,ATPⅢ和IDF的灵敏度、特异度、曲线下面积分别为0.62、0.84、0.73和0.73、0.68、0.70。IDF为参照下,ATPⅢ和CDS的灵敏度、特异度、曲线下面积分别为0.59、0.82、0.70和0.72、0.69、0.70。ATPⅢ为参照下,IDF和CDS的灵敏度、特异度、曲线下面积分别为0.79、0.53、0.71和0.81、0.66、0.74。结论ATPⅢ、CDS、IDF工作定义侧重点不一,IDF定义下的MS患病率最高。 Objective To discuss the application values of the metabolic syndrome (MS) in patients hospitalized with coronary diseases (CHD) in China according to the Third Report of the National Cholesterol Educational Program Expert Panel in 2001 ( NCEP-ATP Ⅲ ), Chinese Diabetes Society ( CDS ) in 2004 and International Diabetes Federation (IDF) in 2005. Methods From June 1, 2005 to Sept. 30, 2005, fifty two hospitals in 7 cities of China participated in the survey, in which all the patients with CHD in cardiology department of each hospital were recruited consecutively. As a result, a total of 3 513 patients with CHD were included in this study. MS were diagnosed by these three definitions respectively. Then the MS prevalence were compared and the agreements of these three criteria were evaluated by the Receiver Operating Characteristic (ROC)curves. Results The MS prevalence were 40.2% ,52.8% ,53.5% among the subjects according to ATPⅢ ,CDS and IDF respectively. In the light of the criterion of CDS, the sensitivity ,specificity and the acreage under the curves(AUC) between ATPⅢ and IDF were 0. 62,0. 84,0. 73 and 0. 73,0. 68,0. 70 respectively. And in the light of the criterion of IDF, the three parameters between ATP Ⅲ and CDS were 0. 59,0. 82,0. 70 and 0.72, 0.69,0.70 respectively. And in the light of the criterion of ATP Ⅲ, the three parameters between IDF and CDS were 0. 79,0. 53,0. 71 and 0. 81,0. 66,0. 74 respectively. Conclusion Different aspects were emphasized among the definitions of ATP Ⅲ, CDS and IDF. The prevalence of MS per IDF is the highest among three definitions.
出处 《同济大学学报(医学版)》 CAS 2008年第3期131-135,共5页 Journal of Tongji University(Medical Science)
基金 北京市科委基金资助项目(D0906002040191)
关键词 冠心病 代谢综合征 患病率 灵敏度 特异度 coronary heart disease metabolic syndrome prevalence sensitivity specificity
  • 相关文献

参考文献9

  • 1Eckle RH, Grundy SM, Zimmet PZ. The metabolism syndrome[ J ]. Lancet,2005,365 : 1415 - 1428.
  • 2中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3093
  • 3Zimmet P,Magliano D,Matsuzawa Y,et al. The metabolic syndrome :a global public health problem and a new definition[J]. J Atheroscler Thromb,2005,12:295 -300.
  • 4Scott MG, James IC, Stephen RD, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [ J ]. Circulation, 2005, 112: 2735 - 2752.
  • 5矫杰,李雅君,赵冬,刘静.国际糖尿病联盟新标准下北京地区成人代谢综合征的特点调查[J].临床内科杂志,2006,23(5):305-306. 被引量:8
  • 6Thomas GN,Ho SY, Janus ED, et al. The US National Cholesterol Education Program Adult Treatment Panel Ⅲ ( NCEP ATP Ⅲ ) prevalence of the metabolic syndrome in a chinese population [ J ]. Diabetes Res Clin Pract, 2005,67:251 - 257.
  • 7刘浩,余金明,潘长玉,陈芳,李觉,胡大一.冠心病病人代谢综合征的现况调查[J].中华医学杂志,2006,86(30):2095-2098. 被引量:24
  • 8HU Dai-yi, PAN Chang-yu, YU Jin-ming. For the China Heart Survey Group. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey[J]. Eur Heart J,2006,27:2573 -2579.
  • 9周北凡,武阳丰,李莹,张林峰.中国成人代谢综合征腰围切点的研究[J].中华心血管病杂志,2005,33(1):81-85. 被引量:82

二级参考文献28

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3093
  • 2中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:476
  • 3见:世界卫生组织编 牛胜田 崔彦红 高凌 等译.腰围和腰臀比[A].见:世界卫生组织编,牛胜田,崔彦红,高凌,等译.肥胖的防治-世界卫生组织咨询会报告[C].北京:人民卫生出版社,2001.894.
  • 4National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation,2002,106:3143-3421.
  • 5Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management.BMJ,1995, 311:158-161.
  • 6Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15:539-553.
  • 7Lemieux I, Almeras N, Mauriege P, et al. Prevalence of 'lypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors.Can J Cardiol ,2002,18:725-732.
  • 8Kahn HS, Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration.Am J Clin Nutr, 2003,78:928-934.
  • 9Molarius A, Seidell JC, Sans S, et al. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA Project.J Clin Epidemiol,1999 ,52:1213-1224.
  • 10WHO consultation. Appropriate body mass index for Asian population and its implications for policy and intervention strategies. Lancet ,2004,363:157-116.

共引文献3161

同被引文献15

  • 1KASAI T, MIYAUCHI K, KUBOTA N, et al. The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease[J]. Atherosclerosis,2008,197:944- 950.
  • 2GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. AmJ Cardiol,1983,51:606 -606.
  • 3FORD E S, GILES W H, DIETZ W H. Prevalence of the metabolicsyndrome among US adults: findings from the Third National Health and Nutrition Examination survey[J].JAMA, 2002,287 : 356 - 859.
  • 4THOMAS G N,HO S Y,JANUS E D,et al. The US national cholesterol education programe adult treatment panel Ⅲ(NCEPATP Ⅲ) prevalence of the meta bolic syndrome in a Chinese population[J]. Diabetes Res Clin Pract,2005,67 :251-257.
  • 5TURHAN H, YASAR A S, BASAR N,et al. High prevalance of metabolic syndrome among young women with premature coronary artery disease[J].Coron Artery Dis, 2005,16:37 -40.
  • 6Jaumdally R J, Lip GY, Patel JV, et al. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: implications of diabetes mellitus[J]. J Intern Med, 2009,265(6) : 689-697.
  • 7Tuunanen H, Ukkonen H, Knuuti J. Myocardial fatty acid metabolism and cardiac performance in heart failure [J]. Curr Cardiol Rep,2008,10 ( 2 ) : 142 - 148.
  • 8Pilz S, Marz W. Free fatty acids as a cardiovascular risk factor [ J ]. Clin Chem Lab Med, 2008,46 (4) : 429 - 434.
  • 9周新.临床生物化学与检验[M].4版,北京:人民卫生出版社,1989年.
  • 10Rhee Y, Paik MJ, Kim KR, et al. Plasma free fatty acid level patterns according to cardiovascular risk status in postmenopausal women[J]. Clin Chim Acta, 2008, 392(1 -2) :11-16.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部